Bavarian Nordic Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bavarian Nordic's estimated annual revenue is currently $235.8M per year.(i)
  • Bavarian Nordic's estimated revenue per employee is $156,336

Employee Data

  • Bavarian Nordic has 1508 Employees.(i)
  • Bavarian Nordic grew their employee count by 21% last year.

Bavarian Nordic's People

NameTitleEmail/Phone
1
Snr VP, Global OperationsReveal Email/Phone
2
Biosafety OfficerReveal Email/Phone
3
Head BiostatisticsReveal Email/Phone
4
Head Quality ControlReveal Email/Phone
5
Head Global Distribution & LogisticsReveal Email/Phone
6
Head North America Supply ChainReveal Email/Phone
7
Head Clinical Data ManagementReveal Email/Phone
8
VP, U.S. Government AffairsReveal Email/Phone
9
Controller, Goverment ReportingReveal Email/Phone
10
VP, DP ManufacturingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M637%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
N/A157%N/AN/A
#6
$0.9M11-39%N/AN/A
#7
$1.7M90%N/AN/A
#8
$0.6M30%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$6.4M366%N/AN/A
Add Company

What Is Bavarian Nordic?

Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.

keywords:N/A

N/A

Total Funding

1508

Number of Employees

$235.8M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bavarian Nordic News

2022-04-17 - Bavarian Nordic begins phase 3 clinical trial of MVA-BN RSV ...

A global, Phase 3 trial of approximately 20,000 older adult volunteers for the Bavarian Nordic A/S MVA-BN RSV vaccine candidate began this...

2022-04-17 - Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults

Bavarian Nordic's vaccine candidate, MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The...

2022-03-30 - New Incentive Programs Established for Members of ...

Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$674.4M160816%N/A
#2
$622.9M1671-35%N/A
#3
N/A177110%N/A
#4
$256.2M186012%N/A
#5
$916.2M3301-5%N/A